Raskin Elizabeth R, Keller Deborah S, Gorrepati Madhu L, Akiel-Fu Sylvie, Mehendale Shilpa, Cleary Robert K
Department of Surgery, Loma Linda University, Loma Linda, California, USA.
GENIE Centre, University College-London, London, England.
JSLS. 2019 Jan-Mar;23(1). doi: 10.4293/JSLS.2018.00073.
The role for the robotic-assisted approach as a minimally invasive alternative to open colorectal surgery is in the evaluation phase. While the benefits of minimally invasive colorectal surgery when compared to the open approach have been clearly demonstrated, the adoption of laparoscopy has been limited. The purpose of this study was to evaluate clinical outcomes, hospital and payer characteristics of patients undergoing robotic-assisted, laparoscopic, and open elective sigmoidectomy for diverticular disease in the United States.
This is a retrospective propensity score-matched analysis. The Premier Healthcare Database was queried for patients with diverticular disease. Patients with diverticular disease who underwent robotic-assisted, laparoscopic, and open sigmoidectomy for diverticular disease from January 2013 through September 2015 were included. Propensity-score matching (1:1) facilitated comparison of robotic-assisted versus open approach and robotic-assisted versus laparoscopic approach. Peri-operative outcomes were assessed for both comparisons.
There were several outcomes advantages for the robotic-assisted approach when compared to laparoscopic and open sigmoidectomy for diverticular disease that included significantly fewer conversions to open ( = .0002), shorter hospital length of stay, fewer postoperative complications-ileus, wound complications, and acute renal failure-and more patients discharged directly to home.
The robotic-assisted minimally invasive approach to elective sigmoidectomy for diverticular disease results in favorable intra-operative and postoperative outcomes when compared to laparoscopic and open approaches.
机器人辅助手术作为开放性结直肠手术的微创替代方法,目前正处于评估阶段。虽然与开放手术相比,微创结直肠手术的优势已得到明确证实,但腹腔镜手术的应用仍受到限制。本研究的目的是评估美国因憩室病接受机器人辅助、腹腔镜和开放性择期乙状结肠切除术患者的临床结局、医院及支付方特征。
这是一项回顾性倾向评分匹配分析。在Premier医疗数据库中查询憩室病患者。纳入2013年1月至2015年9月因憩室病接受机器人辅助、腹腔镜和开放性乙状结肠切除术的患者。倾向评分匹配(1:1)有助于比较机器人辅助手术与开放手术以及机器人辅助手术与腹腔镜手术。对这两种比较的围手术期结局进行评估。
与腹腔镜和开放性乙状结肠切除术相比,机器人辅助手术在憩室病治疗方面有多个结局优势,包括转为开放手术的情况显著减少(P = 0.0002)、住院时间缩短、术后并发症(肠梗阻、伤口并发症和急性肾衰竭)减少,且更多患者可直接出院回家。
与腹腔镜和开放手术相比,机器人辅助微创方法用于憩室病的择期乙状结肠切除术可带来良好的术中及术后结局。